The Living Heart Project

A Translational Research Initiative to Revolutionize Cardiovascular Science Through Realistic Simulation

What if physicians and surgeons could virtually analyze their patients’ health and plan therapies and surgeries using the same advanced simulation technology that the automotive, aerospace, energy and hi-tech industries rely on to test their product before they are built? What if medical devices could be designed and safely tested in the virtual world before ever being tested in the real world?

IF WE apply the power of realistic simulation to human modeling, we can revolutionize medical care.

The Living Heart Project is uniting leading cardiovascular researchers, educators, medical device developers, regulatory agencies, and practicing cardiologists on a shared mission to develop and validate highly accurate personalized digital human heart models. These models will establish a unified foundation for cardiovascular in silico medicine and serve as a common technology base for education and training, medical device design, testing, clinical diagnosis and regulatory science creating an effective path for rapidly translating current and future cutting edge innovations directly into improved patient care.

The Living Heart Project is driven by a growing ecosystem that is fueling the collaborative development of validated, commercially available heart models and exploring novel digital therapies. The Living Heart Project signed a five-year collaborative research agreement with the United States Food and Drug Administration (FDA). Together with the Project participants listed below, testing paradigms beginning with the insertion, placement and performance of pacemaker leads and other cardiovascular devices will be evaluated, bringing the Living Heart Project closer to providing personalized, interventional cardiac-patient care. 


Who is participating in The Living Heart Project